SLC9A9 and neoplasm: Endosomal NHE9 activity exerts a profound pan‐specific effect on membrane persistence of multiple receptors and transporters, and an overall elevation in endocytic uptake.4, 5, 10 Here, we describe a new therapeutic approach that utilizes this gained function by GBM9+ tumour cells to effectively target them for destruction.